GPR119: a promising target for nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GPR119: a promising target for nonalcoholic fatty liver disease

Published:2015-09-23 Issue:1 Volume:30 Page:324-335
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Yang Jin Won¹,Kim Hyo Seon¹,Im Ji Hye¹,Kim Ji Won¹,Jun Dae Won²,Lim Sung Chul³,Lee Kyeong⁴,Choi Jong Min⁵,Kim Sang Kyum⁵,Kang Keon Wook¹

Affiliation:

1. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National UniversitySeoulRepublic of Korea

2. Department of Internal MedicineHan Yang UniversitySeoulRepublic of Korea

3. Department of PathologyCollege of Medicine, Chosun UniversityGwangjuRepublic of Korea

4. College of Pharmacy, Dongguk UniversityGoyangRepublic of Korea

5. College of Pharmacy, Chungnam National UniversityDaejeonRepublic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.15-273771

Reference39 articles.

1. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

2. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis

3. Protein Sensors for Membrane Sterols

4. AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

5. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches;International Journal of Molecular Sciences;2024-08-10

2. Ginsenoside Rg5 Activates the LKB1/AMPK/mTOR Signaling Pathway and Modifies the Gut Microbiota to Alleviate Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet;Nutrients;2024-03-15

3. GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates;Expert Opinion on Investigational Drugs;2024-02-23

4. Regulation and targeting of SREBP-1 in hepatocellular carcinoma;Cancer and Metastasis Reviews;2023-12-01

5. SREBP inhibitors: an updated patent review for 2008-present;Expert Opinion on Therapeutic Patents;2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3